When you sit down with a game, you make a pact with it: you’ll push the buttons, and it will show you what happens when you do. A lot of games don’t really care to interrogate what that means, to use ...

Paige mixes golf with a playful beat, showing that sports can be fun and stylish. Attempted carjacking of a soccer coach goes wrong; 1 man in custody FBI investigates hunting stand with sight line to ...

Axcelis Technologies, Inc. and Veeco Instruments Inc. are merging in a $4.4 billion all-stock deal to create a diversified semiconductor equipment company. The merger aims to broaden product offerings ...

The developer behind Arcaea is bringing a rhythm-visual novel blend to Steam. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Add us as a ...

What makes music unique, unlike other forms of expression or communication? I suspect most people could put together a personal list of several things. But among the most important have to be the ways ...

On June 7, Chicago Sky veteran Courtney Vandersloot was driving to the basket, hoping to score against the Indiana Fever. But before she could take a shot, she fell to the ground, crying out in pain ...

Despite a broader industry downturn that saw its revenues decline sharply, Axcelis Technologies, Inc. is expanding its gross, operating, and free cash flow margins while maintaining a robust balance ...

We’ve been force-fed the idea for decades: The secret to success is routine. Wake up at 5 a.m., step into a punishing physical routine, follow a strict schedule and stick to your plan no matter what.

When a patient's condition changes, nurses are usually the first to notice it. Every second counts when there is a high risk of cardiac arrest, stroke, or respiratory failure. Advanced Cardiovascular ...

I remember the first time I looked into a kaleidoscope as a kid, it was so strange and disarming to me that I threw up a little bit, and then it was confiscated by my parents. Sad, but probably for ...

Rhythm Pharmaceuticals’ push to move obesity patients from jabs to tabs has stayed on beat. A phase 2 trial of the biotech’s next-generation oral candidate hit its primary endpoint, sending the stock ...